BBV87 Chikungunya vaccine

BIOLOGICAL2 trials

Sponsors

International Vaccine Institute, Bharat Biotech International Limited

Conditions

Active Immunisation for Chikungunya Virus InfectionChikungunya

Phase 2

Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asia

TerminatedNCT04566484

International Vaccine InstituteChikungunya

Start: 2021-08-01End: 2025-05-31Updated: 2025-06-22

A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.

RecruitingNCT07555392

Bharat Biotech International LimitedActive Immunisation for Chikungunya Virus Infection

Start: 2026-04-20End: 2027-08-30Target: 1000Updated: 2026-04-29